Future of Personalized Therapy Targeting Aberrant Signaling Pathways in Multiple MyelomaFaiz Anwer, Christy Samaras, Ahmad Iftikhar et al.|Clinical Lymphoma Myeloma & Leukemia|2019Cited by 23
Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical DevelopmentAhmad Iftikhar, Faiz Anwer, Hamza Hassan et al.|Antibodies|2019Cited by 15
Role of investigational monoclonal antibodies in the treatment of multiple myeloma: A systematic review.Hamza Hassan, Faiz Anwer, Ahmad Iftikhar et al.|Journal of Clinical Oncology|2019Cited by 0
POSTER: MM-441 The Efficacy and Safety of Cilta-Cel and Ide-Cel in Relapsed/Refractory Multiple Myeloma: A Meta-AnalysisSyed Imam Naufil, Muhammad Husnain, Zubair Amin et al.|Clinical Lymphoma Myeloma & Leukemia|2025Cited by 0
MM-441: The Efficacy and Safety of Cilta-Cel and Ide-Cel in Relapsed/Refractory Multiple Myeloma: A Meta-AnalysisSyed Imam Naufil, Muhammad Husnain, Zubair Amin et al.|Clinical Lymphoma Myeloma & Leukemia|2025Cited by 0